A randomized, controlled clinical trial comparing efficacy, safety and cost effectiveness of Lornoxicam with Diclofenac Sodium in patients of osteoarthritis knee
Journal Title: Internet Journal of Medical Update - Year 2011, Vol 6, Issue 2
Abstract
Osteoarthritis is a chronic painful condition affecting larger joints; most commonly knee joint. Pharmacological control of pain is the mainstay of management of osteoarthritis. Many patientsfail to achieve satisfactory reduction in pain with one of the most commonly prescribed drugs, diclofenac sodium, even after maximum daily allowed doses. Lornoxicam is a newer molecule in the Indian market promising better pain relief in context of low back pain and post knee replacement surgery pain as compared to standard therapies. As per profile of lornoxicam, if it is better than diclofenac sodium then it will be helpful in managing the patients of osteoarthritis more effectively. Till date no comparative clinical trial has been done to compare these two drugs for the management of osteoarthritis knee. So, to evaluate the same we carried out this study to compare safety, efficacy and cost effectiveness of lornoxicam and diclofenac sodium in relieving pain in patients of osteoarthritis knee. This study is a randomized, open labeled, controlled clinical trial having 40 newly diagnosed patients with osteoarthritis knee. After random allocation into two groups i.e. group D and group L (each having 20 patients); group D received diclofenac sodium 50 mg 12 hourly and group L received lornoxicam 4 mg 8 hourly for a period of 3 months. All patients were assessed with visual analogue scale and 100 meter walking test before starting of therapy, at 15 days and at 1, 2 and 3 months of therapy. Adverse drug reactions and cost of therapy was monitored during the study period. Mean decrease in visual analogue scale and time of 100 meter walking test was statistically significant in lornoxicam group as compared to diclofenac sodium. Gastric irritation was reported in one patient from group L and two patients from group D. Lornoxicam significantly relieves pain of osteoarthritis knee than diclofenac sodium without adversely affecting the tolerability to the patients.
Authors and Affiliations
Vishalkumar Vadgama, Ripal Gharia, Kalpesh Mehta, Ravisaheb Sanjiv, C Tripathi
Keywords
Related Articles
- EP ID EP102871
- DOI -
- Views 129
- Downloads 0
Study on the attitude of “Tomorrow’s Doctors” towards mental illness: A cross-sectional study
Different studies show different attitudes towards mental illness among medical students. This study was initiated to explore the attitude towards mental illness among medical students in a medical college of Manipur. A...
EVOLUTION OF SURGICAL INTERVENTIONS FOR HYDROCEPHALUS: PATIENT PREFERENCES AND THE NEED FOR PROPER INFORMATION
The treatment of hydrocephalus has undergone remarkable transformation since it was first documented over two thousand years ago. Currently, the focus of hydrocephalus research is on minimally invasive techniques of trea...
Prevalence of obesity and hypertension among adults in Ogbomoso, Nigeria
Developing countries are now witnessing an increase in overweight; obesity and obesity-related morbidity. We determined the prevalence of obesity using the measure of body mass index (BMI) and hypertension and the associ...
RADIATION EXPOSURE FROM DIAGNOSTIC RADIOGRAPHY: AN ASSESSMENT OF X-RAY BEAM COLLIMATION PRACTICE IN SOME NIGERIAN HOSPITALS
This study was carried out to evaluate the X-ray beam collimation practice, among radiographers, as a measure of radiation protection for patients undergoing radiodiagnostic investigations. Inadequate X-ray beam collimat...
Evaluation of nested Polymerase Chain Reaction targeting hup B gene in the diagnosis of tubercular ascites
Abdominal tuberculosis usually has nonspecific presentation, frequently mimicking other diseases. Because of the limitations of the conventional methods of diagnosis of extra pulmonary tuberculosis, focus is shifted to m...